Jiang Yongshuai

Prof. Jiang Yongshuai


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2025 in eClinicalMedicine
Verified
Journal Article
Open access
LYLinna Yuan
Linna Yuan
JTJunxian Tao
Junxian Tao
JWJiacheng Wang
Jiacheng Wang
WSWei She
Wei She
YZYuping Zou
Yuping Zou
MZMingming Zhang
Mingming Zhang
Asthma is the second leading cause of mortality among chronic respiratory illnesses. This study provided a comprehensive analysis of the burden of asthma. Data on asthma were extracted from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021. We focused on the effects of age, sex, risk factors, and the socio-demographic index (SDI) on the burden of asthma and calculated the average annual percent change (AAPC) via joinpoint regression. Two-sample Mendelian randomization (MR) was adopted to estimate the causal relationships between risk factors and asthma. The Bayesian age-period-cohort (BAPC) model was used to predict incidence patterns of asthma from 2022 to 2050. In 2021, there was an observed prevalence of asthma, with 3,340 cases per 100,000 people. Males who were below 20 years old had a greater prevalence of asthma. The incidence and prevalence correlated positively with the SDI, whereas mortality and disability-adjusted life years (DALYs) correlated negatively. The contribution of high body mass index (BMI) to asthma DALYs increased by 4.3% worldwide between 1990 and 2021. MR studies have confirmed that high BMI and smoking can increase the risk of asthma. The prediction results indicated that the global age-standardised incidence rate will remain high from 2022 to 2050. The global mortality of patients with asthma is a significant concern. The analysis of the burden of asthma can help formulate public health policies, allocate resources, and prevent asthma. This study was supported by the 10.13039/501100001809 National Natural Science Foundation of China ; Program for Young Talents of Basic Research in Universities of Heilongjiang Province; Marshal Initiative Funding; Mathematical Tianyuan Fund of the 10.13039/501100001809 National Natural Science Foundation of China ; XingLian Outstanding Talent Support Program 2024.

Verified
Journal Article
Open access
PDF file
CWChenguang Wang
Chenguang Wang
LWLianzong Wang
Lianzong Wang
YDYu Ding
Yu Ding
XLXiaoyan Lu
Xiaoyan Lu
GZGuosi Zhang
Guosi Zhang
LXLiangde Xu
Liangde Xu
The rapid development of new generation sequencing technology has deepened the understanding of genomes and functional products. RNA-sequencing studies in mammals show that approximately 85% of the DNA sequences have RNA products, for which the length greater than 200 nucleotides (nt) is called long non-coding RNAs (lncRNA). LncRNAs now have been shown to play important epigenetic regulatory roles in key molecular processes, such as gene expression, genetic imprinting, histone modification, chromatin dynamics, and other activities by forming specific structures and interacting with all kinds of molecules. This paper mainly discusses the correlation between the structure and function of lncRNAs with the recent progress in epigenetic regulation, which is important to the understanding of the mechanism of lncRNAs in physiological and pathological processes.

9 January 2016 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
QJQinghua Jiang
Qinghua Jiang
SJShuilin Jin
Shuilin Jin
JYJiang Yongshuai
Jiang Yongshuai
MLMingzhi Liao
Mingzhi Liao
RFRennan Feng
Rennan Feng
JHJunwei Hao
Junwei Hao

1 April 2014 in Neurobiology of Aging
Verified
Journal Article
Closed access
GLGuiyou Liu
Guiyou Liu
LYLifen Yao
Lifen Yao
JLJiafeng Liu
Jiafeng Liu
JYJiang Yongshuai
Jiang Yongshuai
GMGuoda Ma
Guoda Ma
KLKeshen Li
Keshen Li

10 April 2013 in NeuroMolecular Medicine
Verified
Journal Article
Closed access
PDF file
GLGuiyou Liu
Guiyou Liu
SZShuyan Zhang
Shuyan Zhang
ZCZhiyou Cai
Zhiyou Cai
GMGuoda Ma
Guoda Ma
LZLiangcai Zhang
Liangcai Zhang
KLKeshen Li
Keshen Li

24 March 2025 in Biomarker Research
Verified
Journal Article
Open access
PDF file
YMYingnan Ma
Yingnan Ma
HCHaiyan Chen
Haiyan Chen
WLWenhua Lv
Wenhua Lv
SWSiyu Wei
Siyu Wei
YZYuping Zou
Yuping Zou
JYJiang Yongshuai
Jiang Yongshuai
Background: To provide insights into rheumatoid arthritis (RA) epidemiological trends, including prevalence, incidence, disability-adjusted life years (DALYs), corresponding average annual percentage change (AAPC), gender disparities, regional variations, age-specific rates, socio-economic correlations, risk factors, and future projections. Methods: Data were extracted from the Global Burden of Disease Study (GBD) 2021. AAPC was calculated by joinpoint regression and two-sample Mendelian randomization (MR) analysis was performed to verify the causal relationship between the smoking factor and RA. The future incidence trend was predicted by the Bayesian age-period-cohort (BAPC) model. Results: Global age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) increased significantly while age-standardized DALYs rate (ASDR) decreased from 1990 to 2021. Regional variations were pronounced, with Andean Latin America reporting the highest burden. Females consistently exhibited higher age-standardized rate (ASR) across all metrics. Age-specific prevalence, incidence, and DALYs rates peaked at different age groups, highlighting complex demographic dynamics. Socio-demographic index (SDI) analysis demonstrated a positive correlation between RA burden and socio-economic development. The two-sample MR analysis confirmed a causal effect between smoking and RA. From 2022 to 2050, the ASIR will increase moderately. Conclusions: The study underscores the escalating burden of RA globally, emphasizing the need for healthcare providers to be aware of the effects of aging populations and other societal factors on the risk of developing RA, and to develop targeted interventions, including smoking cessation programs, age- and gender-appropriate healthcare, and early diagnosis strategies.